SCOPUS 정보 검색 플랫폼

Volumn 2, Issue , 2008, Pages

Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: A case report

(2) de Klerk, Timothy A a Steel, David H W a

a SUNDERLAND EYE INFIRMARY (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARGON PLASMA COAGULATION; ARTICLE; CASE REPORT; EYE PHOTOGRAPHY; HEMANGIOBLASTOMA; HUMAN; MALE; OPTIC NERVE TUMOR; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA EXUDATE; RETINA MACULA EDEMA; RETINAL HEMANGIOBLASTOMA; SLIT LAMP; TUMOR VOLUME; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VON HIPPEL LINDAU DISEASE;

EID: 45849115062 PISSN: 17521947 EISSN: 17521947 Source Type: Journal
DOI: 10.1186/1752-1947-2-182 Document Type: Article

Times cited : (8)

References (9)

1
- 0000104601
- Discussion
- 10.1016/S0161-6420(99)00062-7
- Shields JA Discussion Ophthalmology 2000, 107:54. 10.1016/ S0161-6420(99)00062-7
- (2000) Ophthalmology , vol.107 , pp. 54
- Shields, J.A.¹

2
- 0034033318
- Therapeutic options for capillary papillary hemangiomas
- 10.1016/S0161-6420(99)00018-4 10647718
- Garcia-Arumi J Sararols LH Cavero L Escalada F Corcostegui BF Therapeutic options for capillary papillary hemangiomas Ophthalmology 2000, 107:48-54. 10.1016/S0161-6420(99)00018-4 10647718
- (2000) Ophthalmology , vol.107 , pp. 48-54
- Garcia-Arumi, J.¹ Sararols, L.H.² Cavero, L.³ Escalada, F.⁴ Corcostegui, B.F.⁵

3
- 0033661652
- Juxtapapillary capillary hemangiomas. Clinical features and visual outcomes
- 10.1016/S0161-6420(00)00422-X 11097604
- McCabe CM Flynn HW Shields CL Shields JA Regillo CD McDonald HR Berrocal MH Gass JD Mieler WF Juxtapapillary capillary hemangiomas. Clinical features and visual outcomes Ophthalmology 2000, 107:2240-2248. 10.1016/ S0161-6420(00)00422-X 11097604
- (2000) Ophthalmology , vol.107 , pp. 2240-2248
- McCabe, C.M.¹ Flynn, H.W.² Shields, C.L.³ Shields, J.A.⁴ Regillo, C.D.⁵ McDonald, H.R.⁶ Berrocal, M.H.⁷ Gass, J.D.⁸ Mieler, W.F.⁹

4
- 33846205060
- Molecular pathology of eyes with von Hippel-Lindau (VHL) disease: A review
- 1971131 17218907 10.1097/01.iae.0000244659.62202.ee
- Chan CC Collins AB Chew EY Molecular pathology of eyes with von Hippel-Lindau (VHL) disease: A review Retina 2007, 27:1-7. 1971131 17218907 10.1097/01.iae.0000244659.62202.ee
- (2007) Retina , vol.27 , pp. 1-7
- Chan, C.C.¹ Collins, A.B.² Chew, E.Y.³

5
- 0036712736
- Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416
- 10.1016/S0161-6420(02)01159-4 12208726
- Aiello LP George DJ Cahill MT Wong JS Cavallerano J Hannah AL Kaelin WG Jr Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416 Ophthalmology 2002, 109:1745-1751. 10.1016/S0161-6420(02)01159-4 12208726
- (2002) Ophthalmology , vol.109 , pp. 1745-1751
- Aiello, L.P.¹ George, D.J.² Cahill, M.T.³ Wong, J.S.⁴ Cavallerano, J.⁵ Hannah, A.L.⁶ Kaelin Jr., W.G.⁷

6
- 0038015673
- Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas
- 10.1016/S0002-9394(03)00101-6 12834696
- Girmens JF Erginay A Massin P Scigalla P Gaudric A Richard S Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas Am J Ophthalmol 2003, 136:194-196. 10.1016/S0002-9394(03)00101-6 12834696
- (2003) Am J Ophthalmol , vol.136 , pp. 194-196
- Girmens, J.F.¹ Erginay, A.² Massin, P.³ Scigalla, P.⁴ Gaudric, A.⁵ Richard, S.⁶

7
- 29944437896
- Ocular Manifestations of Von Hippel-Lindau disease: Clinical and genetic investigations
- 1447586 17057815
- Chew EY Ocular Manifestations of Von Hippel-Lindau disease: Clinical and genetic investigations Trans Am Ophthalmol Soc 2005, 103:495-511. 1447586 17057815
- (2005) Trans Am Ophthalmol Soc , vol.103 , pp. 495-511
- Chew, E.Y.¹

8
- 33846969162
- Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina
- 10.1097/IAE.0b013e318030a290 17290195
- Dahr SS Cusick M Rodriguez-Coleman H Srivastava SK Thompson DJ Linehan WM Ferris FL Chew EY Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina Retina 2007, 27:150-158. 10.1097/IAE.0b013e318030a290 17290195
- (2007) Retina , vol.27 , pp. 150-158
- Dahr, S.S.¹ Cusick, M.² Rodriguez-Coleman, H.³ Srivastava, S.K.⁴ Thompson, D.J.⁵ Linehan, W.M.⁶ Ferris, F.L.⁷ Chew, E.Y.⁸

9
- 0033527584
- Selection and analysis of an optmised anti-VEGF antibody: Crystal structure of an affinity matured Fab in complex with antigen
- 10.1006/jmbi.1999.3192 10543973
- Chen Y Wiesmann C Fuh G Li B Christinger HW McKay P de Vos AM Lowman HB Selection and analysis of an optmised anti-VEGF antibody: Crystal structure of an affinity matured Fab in complex with antigen J Mol Biol 1999, 293:865-881. 10.1006/jmbi.1999.3192 10543973
- (1999) J Mol Biol , vol.293 , pp. 865-881
- Chen, Y.¹ Wiesmann, C.² Fuh, G.³ Li, B.⁴ Christinger, H.W.⁵ McKay, P.⁶ de Vos, A.M.⁷ Lowman, H.B.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.